Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Filings indexed 1,179 across all filing types
Latest filing 2019-10-18 Declaration of Voting R…
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Otrzymanie zawiadomienia w trybie art. 69 OfertPublU - objęcie akcji Selvita S.A. wyemitowanych w związku z podziałem Ryvu Therapeutics S.A. - Content (PL)
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document text is very short (834 characters) and appears to be a formal notification from the Management Board ('Zarząd spółki') of Selvita S.A. It references a previous current report ('raport bieżący') and states that a notification ('zawiadomienia') received from a shareholder (Augebit FIZ) regarding shareholding changes, prepared based on Article 69 of the Public Offering Act, is being submitted ('przekazuje w załączeniu do niniejszego raportu'). This structure—a brief announcement referencing an attached or enclosed document detailing a change in significant share ownership—strongly suggests a notification of a change in major shareholding. This aligns best with the Major Shareholding Notification (MRQ) definition, which covers notifications of changes in significant share ownership levels crossing thresholds.
2019-10-18 Polish
Zawarcie umowy lock-up na akcjach Emitenta - Content (PL)
Share Issue/Capital Change Classification · 99% confidence The document text, written in Polish, discusses the execution of a 'lock-up' agreement ('umowy zakazu rozporządzania akcjami lock-up') concerning a significant number of shares (3,500,000 Series A preferred shares and 1,490,880 Series B common shares) by a key shareholder (the CEO of Ryvu Therapeutics S.A., formerly Selvita S.A.). This agreement restricts the disposal of these shares for a 12-month period following the first listing date. This type of restriction on share ownership and transfer is directly related to capital structure changes, financing activities, or major ownership commitments following a corporate action (like a spin-off or listing). Among the provided categories, 'Capital/Financing Update' (CAP) is the most appropriate fit for documenting significant contractual restrictions on the transfer of a large block of shares by an insider/major shareholder, often associated with recent fundraising or corporate restructuring events.
2019-10-18 Polish
Zawiadomienia_art. 19 MAR_Selvita SA_Dzień Przydziału
Director's Dealing Classification · 99% confidence The document text is titled "Powiadomienie o transakcji/transakejach*, o których mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of transactions(s) referred to in Article 19(1) of the MAR Regulation). Article 19 of the Market Abuse Regulation (MAR) specifically deals with transactions conducted by persons discharging managerial responsibilities (PDMRs) and persons closely associated with them. The content details a specific transaction involving shares of SELVITA S.A. by an executive (Bogusław Sieczkowski, Prezes Zarządu - CEO/President of the Management Board). This structure and content directly correspond to insider dealing or director's dealing reports required under MAR. Among the provided codes, 'Director's Dealing' (DIRS) is the most appropriate classification for reports of personal share transactions by company directors and executives.
2019-10-17 Polish
Informacje uzyskane na podstawie art. 19 Rozporządzenia MAR - objęcie akcji Selvita S.A. wyemitowanych w związku z podziałem Ryvu Therapeutics S.A. - Content (PL)
Major Shareholding Notification Classification · 99% confidence The document text is in Polish and discusses notifications received by the management board ('Zarząd') regarding transactions or holdings changes involving key management personnel (CEO, VPs, Board Members, Proxies) and closely associated entities. The core subject is the reporting of share transactions or holdings changes by individuals discharging managerial responsibilities ('osób pełniących obowiązki zarządcze'). This directly corresponds to the definition of Director's Dealing (insider trades). Keywords supporting this: 'powiadomień od osób pełniących obowiązki zarządcze' (notifications from persons discharging managerial responsibilities), listing names of management/supervisory board members, and mentioning share allocation ('objęciem akcji Spółki'). This aligns perfectly with the definition for Director's Dealing (Code: DIRS). The document length is short (1353 chars) and appears to be the announcement itself, not the detailed form, but the content is specific enough to classify it as DIRS rather than a general RPA or RNS.
2019-10-17 Polish
Zawiadomienia art. 69 OfertPublU_Selvita SA
Director's Dealing Classification · 98% confidence The document contains multiple notifications submitted to the Polish Financial Supervision Authority (KOMISJA NADZORU FINANSOWEGO) regarding changes in shareholding percentages in Selvita S.A. Specifically, it details transactions/allotments that caused the shareholding of Paweł Przewięźlikowski to cross the 33 1/3% threshold and Bogusław Sieczkowski to cross the 5% threshold, as well as a notification from Nationale-Nederlanden regarding their holdings crossing the 5% threshold. These filings, referencing Article 69 of the Polish Public Offering Act, are mandatory disclosures when an investor's stake in a publicly traded company crosses specific statutory thresholds (5%, 10%, 33 1/3%, 50%, 75%, 90%). This directly corresponds to the definition of Major Shareholding Notification (MRQ).
2019-10-17 Polish
Otrzymanie zawiadomień w trybie art. 69 OfertPublU - objęcie akcji Selvita S.A. wyemitowanych w związku z podziałem Ryvu Therapeutics S.A. - Content (PL)
Major Shareholding Notification Classification · 95% confidence The document text is very short (755 characters) and written in Polish. It states that the Management Board of Selvita S.A. is informing about receiving notifications ('zawiadomień') from several individuals/entities regarding share ownership changes, pursuant to Article 69 of the Public Offering Act. Crucially, it states that the company is forwarding these notifications 'w załączeniu do niniejszego raportu' (attached to this report). This structure—announcing the receipt of specific regulatory notifications and attaching them—strongly suggests this is an announcement about the filing/publication of other documents, rather than the full regulatory filing itself. Since the content specifically concerns changes in significant share ownership ('objęciem akcji Spółki' - acquisition of company shares), the most appropriate category is Major Shareholding Notification (MRQ). However, given the 'MENU VS MEAL' rule, if this is merely an announcement attaching the actual notifications, it could be RPA or RNS. Since MRQ is a specific category for shareholding changes, and this document is the mechanism by which those changes are disclosed to the market, MRQ is the primary fit for the *subject matter*. If the attached documents are the actual MRQ filings, this announcement is the cover. Given the context of regulatory filings about share ownership changes, MRQ is the best fit for the subject matter being disclosed, even if the document itself is a brief announcement.
2019-10-17 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.